Error in Brand Price Premiums for Sevikar 20/5 and Sevikar 40/10 in the 1 October 2024 Schedule
01 Oct 2024
The Brand Price Premiums for the following Sevikar products have been amended in the 1 October 2024 Schedule:
- Sevikar 20/5 brand of olmesartan 20 mg + amlodipine 5 mg
- PBS code 13449W (max quantity 60) has changed from $6.00 to $4.22
- PBS code 5292M (max quantity 30) has changed from $3.00 to $2.11.
- Sevikar 40/10 brand of olmesartan 40 mg + amlodipine 10 mg
- PBS code 13943W (maximum quantity 60) has changed from $6.00 to $5.22
- PBS code 5294P (maximum quantity 30) has changed from $3.00 to $2.61.
These changes were due to a processing error, and the premiums will be reinstated back to the amounts in effect prior to 1 October in the 1 November 2024 PBS Schedule.
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
- Medicine Shortage
Popular Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy